Mirtazapine
Synonyms / Brand Names: Mirtazapina, Mirtazapinum, Mirtazepine, Mepirzepine, Remeron, Remeron Soltab, Zispin, Remergil, Norset, Rexer, Remergon, Mirtabene, Avanza, Mirtazon, Axit, Mirtaz, Promyrtil
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Dosing and Administration
The recommended starting dose for Mirtazapine tablets USP is 15 mg/day, administered in a single dose, preferably in the evening prior to sleep. In the controlled clinical trials establishing the efficacy of Mirtazapine in the treatment of major depressive disorder, the effective dose range was generally 15 mg/day to 45 mg/day. While the relationship between dose and satisfactory response in the treatment of major depressive disorder for Mirtazapine has not been adequately explored, patients not responding to the initial 15 mg dose may benefit from dose increases up to a maximum of 45 mg/day. Mirtazapine has an elimination half-life of approximately 20 to 40 hours, therefore, dose changes should not be made at intervals of less than one to two weeks in order to allow sufficient time for evaluation of the therapeutic response to a given dose.
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Mirtazapine
Return to top
Publication Resources
Most Recent Articles on Mirtazapine
Review Articles on Mirtazapine
Articles on Mirtazapine in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Mirtazapine
Return to top
Trial Resources
Ongoing Trials with Mirtazapine at Clinical Trials.gov
Trial Results with Mirtazapine
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Mirtazapine
Cochrane Collaboration on Mirtazapine
Cost Effectiveness of Mirtazapine
Return to top
Media Resources
Powerpoint Slides on Mirtazapine
Images of Mirtazapine
Podcasts & MP3s on Mirtazapine
Videos on Mirtazapine
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Mirtazapine
Discussion Groups on Mirtazapine
Patient Handouts on Mirtazapine
Blogs on Mirtazapine
Mirtazapine in the News
Mirtazapine in the Marketplace
Return to top
International Resources
Mirtazapine en Español
Return to top
Adapted from the FDA Package Insert.